Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fresenius Medical Care Corp (FMS)

Fresenius Medical Care Corp (FMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,444,436
  • Shares Outstanding, K 605,660
  • Annual Sales, $ 19,542 M
  • Annual Income, $ 2,341 M
  • 60-Month Beta 1.47
  • Price/Sales 1.26
  • Price/Cash Flow 10.90
  • Price/Book 1.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.68
  • Number of Estimates 1
  • High Estimate 0.68
  • Low Estimate 0.68
  • Prior Year 0.66
  • Growth Rate Est. (year over year) +3.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.39 +7.94%
on 01/15/20
40.41 -0.12%
on 02/11/20
+2.91 (+7.77%)
since 01/14/20
3-Month
35.62 +13.31%
on 12/18/19
40.41 -0.12%
on 02/11/20
+4.31 (+11.96%)
since 11/14/19
52-Week
31.63 +27.60%
on 10/02/19
42.75 -5.59%
on 05/03/19
+2.31 (+6.07%)
since 02/14/19

Most Recent Stories

More News
Should Value Investors Pick Fresenius Medical (FMS) Stock?

Let's see if Fresenius Medical (FMS) stock is a good choice for value-oriented investors right now from multiple angles.

FMS : 40.36 (+1.03%)
Fresenius (FMS) Upgraded to Buy: Here's What You Should Know

Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

FMS : 40.36 (+1.03%)
Is Fresenius (FMS) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 40.36 (+1.03%)
Should Value Investors Buy Fresenius (FMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 40.36 (+1.03%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 40.36 (+1.03%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 40.36 (+1.03%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 40.36 (+1.03%)
Should Value Investors Buy Fresenius (FMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 40.36 (+1.03%)
Fresenius Medical Care Celebrates 10th Anniversary and Expansion of Their Dialysis Center With Enhanced Home Therapy Support in Perth, Western Australia

Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia. Celebrating the 10th...

FMS : 40.36 (+1.03%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 40.36 (+1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade FMS with:

Business Summary

Fresenius Medical Care provides a range of products for both treatment modalities, hemmodialysis and peritoneal dialysis, and is a full service provider of dialysis care. They provide dialysis treatment and related laboratory and diagnostic services at more than 1,000 dialysis clinics. They manufacture...

See More

Key Turning Points

2nd Resistance Point 40.57
1st Resistance Point 40.46
Last Price 40.36
1st Support Level 40.18
2nd Support Level 40.01

See More

52-Week High 42.75
Last Price 40.36
Fibonacci 61.8% 38.50
Fibonacci 50% 37.19
Fibonacci 38.2% 35.88
52-Week Low 31.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar